GLENMARK

Glenmark Pharmaceuticals Ltd is a global research-driven pharmaceutical company headquartered in India, operating in the pharmaceutical industry. The company is involved in generics, specialty products, and innovative medicines, with business segments including generics, specialty, and over-the-counter (OTC) products. Glenmark has a presence in over 80 countries, including India, North America, Europe, and emerging markets. It operates 11 manufacturing facilities and four research and development centers. The company's core therapeutic areas are Dermatology, Respiratory, and Oncology. Glenmark's product portfolio includes branded generics, specialty products, and innovative medicines focused on these therapeutic segments. No information on founding details, key management, subsidiaries, or stock exchange listings is provided.